semaglutide dacula GLP-1 Medical Weight Loss Lawrenceville GA Semaglutide Weight Loss Injections &
Description
Clinical Evidence:SURMOUNT-1 Trial: A Phase 2 study in 338 adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m with comorbidities) demonstrated: 24.2% weight loss at 48 weeks with the 12 mg dose
obesity-focused biotech
One consideration is the medication's effect on gastric emptying
The study enrolled more than 2,300 adults with obesity or overweight and at least one weight-related comorbidity who did not have diabetes
We wanna make sure that we're following up
